Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRX3 | hg38_v1_chr16_-_54286763_54286803 | 0.16 | 3.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_55024250 Show fit | 8.44 |
ENST00000231009.3
|
granzyme K |
|
chr1_+_26317950 Show fit | 7.19 |
ENST00000374213.3
|
CD52 molecule |
|
chr13_-_46142834 Show fit | 7.18 |
ENST00000674665.1
|
lymphocyte cytosolic protein 1 |
|
chr1_+_116754422 Show fit | 5.98 |
ENST00000369478.4
ENST00000369477.1 |
CD2 molecule |
|
chr2_+_89936859 Show fit | 5.65 |
ENST00000474213.1
|
immunoglobulin kappa variable 2D-30 |
|
chr14_-_106038355 Show fit | 5.49 |
ENST00000390597.3
|
immunoglobulin heavy variable 2-5 |
|
chr2_-_89222461 Show fit | 5.14 |
ENST00000482769.1
|
immunoglobulin kappa variable 2-28 |
|
chr14_-_106470788 Show fit | 4.54 |
ENST00000434710.1
|
immunoglobulin heavy variable 3-43 |
|
chr2_-_136118142 Show fit | 4.23 |
ENST00000241393.4
|
C-X-C motif chemokine receptor 4 |
|
chr14_-_105987068 Show fit | 4.20 |
ENST00000390594.3
|
immunoglobulin heavy variable 1-2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 82.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 15.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 8.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.6 | 8.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 8.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 6.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 6.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 6.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.3 | 5.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.3 | 5.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 35.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 28.0 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 10.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 10.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 6.9 | GO:0005769 | early endosome(GO:0005769) |
0.5 | 6.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 6.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 4.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 3.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 51.9 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 35.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 10.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 7.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 6.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 5.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 5.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 4.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 4.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 4.0 | GO:0008143 | poly(A) binding(GO:0008143) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 8.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 7.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 5.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 4.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 3.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 6.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 4.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 4.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 4.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 3.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 3.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 2.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |